WEREWOLF THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Mar 2020)
What this means for you
This application is over — abandoned 05 Mar 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87783343
- Mark type
- Stylized text
- Filed
- 04 Feb 2018
- Published for opposition
- 10 Jul 2018
- Abandoned
- 05 Mar 2020
- Attorney of record
- Gwenn Roos
Goods and services
- Class 042 — Scientific and technological services: Research and development and consultation related thereto in the field of cancer and oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of cancer and oncology; Research and development of vaccines and medicines; Research in the field of cancer and oncology; Research on the subject of pharmaceuticals; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Compiling data for research purposes in the field of medical science and medical consultancy; Laboratory research in the field of cancer and oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and oncology; Medical and scientific research information in the field of cancer and oncology; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and oncology; Technical research in the field of pharmaceutical studies; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- MPM Capital LLC, Cambridge, MA, US
- MPM Capital LLC, Cambridge, MA, US
Prosecution history
- 04 May 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 May 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2019 — SOU EXTENSION 2 GRANTED
- 04 Sept 2019 — SOU EXTENSION 2 FILED
- 22 Oct 2019 — NOTICE OF REVIVAL - E-MAILED
- 22 Oct 2019 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 22 Oct 2019 — PETITION TO REVIVE-GRANTED
- 22 Oct 2019 — TEAS PETITION TO REVIVE RECEIVED
- 07 Oct 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Oct 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 03 May 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2019 — SOU EXTENSION 1 GRANTED
- 04 Mar 2019 — SOU EXTENSION 1 FILED
- 02 May 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL